Early Aggressive Intraocular Pressure Lowering, Target Intraocular Pressure, and a Novel Concept for Glaucoma Care

Kuldev Singh, Anurag Shrivastava

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Early diagnosis of glaucomatous optic nerve damage offers the potential for early treatment which may prevent vision loss from this neurodegenerative disease. Even in patients who do not begin early treatment, early diagnosis allows for better monitoring of disease at a stage where the stakes are lower relative to later stages of the disease. For these reasons, early diagnosis of glaucomatous optic nerve disease is desirable and opens the door for appropriately aggressive therapy. The target intraocular pressure (IOP) concept is widely employed by glaucoma practitioners. Although there have been no randomized clinical trials or other high-quality studies showing the benefits of setting a target IOP versus not using this approach, there is ample evidence that lowering IOP slows glaucoma progression and, in general, lower is better, regardless of disease stage and baseline IOP level. We propose an alternative approach to managing glaucoma without the use of the target IOP concept and suggest that this market IOP concept should be compared with the target IOP approach in an appropriately powered comparative clinical trial.

Original languageEnglish (US)
JournalSurvey of Ophthalmology
Volume53
Issue number6 SUPPL.
DOIs
StatePublished - Nov 2008
Externally publishedYes

Fingerprint

Intraocular Pressure
Glaucoma
Early Diagnosis
Optic Nerve Diseases
Optic Nerve
Neurodegenerative Diseases
Therapeutics
Randomized Controlled Trials
Clinical Trials

Keywords

  • early diagnosis
  • early treatment
  • glaucoma
  • intraocular pressure (IOP)
  • market IOP
  • target IOP

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Early Aggressive Intraocular Pressure Lowering, Target Intraocular Pressure, and a Novel Concept for Glaucoma Care. / Singh, Kuldev; Shrivastava, Anurag.

In: Survey of Ophthalmology, Vol. 53, No. 6 SUPPL., 11.2008.

Research output: Contribution to journalArticle

@article{859af91f43914f2e9ee8ff6728829110,
title = "Early Aggressive Intraocular Pressure Lowering, Target Intraocular Pressure, and a Novel Concept for Glaucoma Care",
abstract = "Early diagnosis of glaucomatous optic nerve damage offers the potential for early treatment which may prevent vision loss from this neurodegenerative disease. Even in patients who do not begin early treatment, early diagnosis allows for better monitoring of disease at a stage where the stakes are lower relative to later stages of the disease. For these reasons, early diagnosis of glaucomatous optic nerve disease is desirable and opens the door for appropriately aggressive therapy. The target intraocular pressure (IOP) concept is widely employed by glaucoma practitioners. Although there have been no randomized clinical trials or other high-quality studies showing the benefits of setting a target IOP versus not using this approach, there is ample evidence that lowering IOP slows glaucoma progression and, in general, lower is better, regardless of disease stage and baseline IOP level. We propose an alternative approach to managing glaucoma without the use of the target IOP concept and suggest that this market IOP concept should be compared with the target IOP approach in an appropriately powered comparative clinical trial.",
keywords = "early diagnosis, early treatment, glaucoma, intraocular pressure (IOP), market IOP, target IOP",
author = "Kuldev Singh and Anurag Shrivastava",
year = "2008",
month = "11",
doi = "10.1016/j.survophthal.2008.08.007",
language = "English (US)",
volume = "53",
journal = "Survey of Ophthalmology",
issn = "0039-6257",
publisher = "Elsevier USA",
number = "6 SUPPL.",

}

TY - JOUR

T1 - Early Aggressive Intraocular Pressure Lowering, Target Intraocular Pressure, and a Novel Concept for Glaucoma Care

AU - Singh, Kuldev

AU - Shrivastava, Anurag

PY - 2008/11

Y1 - 2008/11

N2 - Early diagnosis of glaucomatous optic nerve damage offers the potential for early treatment which may prevent vision loss from this neurodegenerative disease. Even in patients who do not begin early treatment, early diagnosis allows for better monitoring of disease at a stage where the stakes are lower relative to later stages of the disease. For these reasons, early diagnosis of glaucomatous optic nerve disease is desirable and opens the door for appropriately aggressive therapy. The target intraocular pressure (IOP) concept is widely employed by glaucoma practitioners. Although there have been no randomized clinical trials or other high-quality studies showing the benefits of setting a target IOP versus not using this approach, there is ample evidence that lowering IOP slows glaucoma progression and, in general, lower is better, regardless of disease stage and baseline IOP level. We propose an alternative approach to managing glaucoma without the use of the target IOP concept and suggest that this market IOP concept should be compared with the target IOP approach in an appropriately powered comparative clinical trial.

AB - Early diagnosis of glaucomatous optic nerve damage offers the potential for early treatment which may prevent vision loss from this neurodegenerative disease. Even in patients who do not begin early treatment, early diagnosis allows for better monitoring of disease at a stage where the stakes are lower relative to later stages of the disease. For these reasons, early diagnosis of glaucomatous optic nerve disease is desirable and opens the door for appropriately aggressive therapy. The target intraocular pressure (IOP) concept is widely employed by glaucoma practitioners. Although there have been no randomized clinical trials or other high-quality studies showing the benefits of setting a target IOP versus not using this approach, there is ample evidence that lowering IOP slows glaucoma progression and, in general, lower is better, regardless of disease stage and baseline IOP level. We propose an alternative approach to managing glaucoma without the use of the target IOP concept and suggest that this market IOP concept should be compared with the target IOP approach in an appropriately powered comparative clinical trial.

KW - early diagnosis

KW - early treatment

KW - glaucoma

KW - intraocular pressure (IOP)

KW - market IOP

KW - target IOP

UR - http://www.scopus.com/inward/record.url?scp=56549105021&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56549105021&partnerID=8YFLogxK

U2 - 10.1016/j.survophthal.2008.08.007

DO - 10.1016/j.survophthal.2008.08.007

M3 - Article

C2 - 19038622

AN - SCOPUS:56549105021

VL - 53

JO - Survey of Ophthalmology

JF - Survey of Ophthalmology

SN - 0039-6257

IS - 6 SUPPL.

ER -